"10.1371_journal.pone.0047631","none","2012-10-16T00:00:00Z","Matthias Seehase; Jennifer J P Collins; Elke Kuypers; Reint K Jellema; Daan R M G Ophelders; Olga L Ospina; J Perez-Gil; Federico Bianco; Raffaella Garzia; Roberta Razzetti; Boris W Kramer","Department of Pediatrics, Maastricht University Medical Center, Maastricht, The Netherlands; Research and Development Department, Chiesi Farmaceutici SpA, Parma, Italy; Department of Biochemistry, Faculty of Biology, Complutense University, Madrid, Spain; Department of Physics, Pontificia Universidad Javeriana, Bogota, Colombia","Conceived and designed the experiments: MS JJPC BWK OLO JPG. Performed the experiments: MS JJPC EK RKJ DRMGO BWK OLO JPG. Analyzed the data: MS JJPC EK BWK OLO JPG. Contributed reagents/materials/analysis tools: RG RR FB. Wrote the paper: MS JJPC EK BWK JPG. Data interpretation: MS JJPC EK JPG FB RG RR BWK. Manuscript revision: MS JJPC EK RKJ DO JPG FB RG RR BWK.","The authors have the following interests. This study was funded by Chiesi Pharmaceutici SpA (Parma, Italy), which is the employer of authors Raffaella Garzia and Roberta Razzetti. Preparations of CHF 5633 synthetic surfactant and Curosurf® were also supplied by Chiesi Pharmaceutici SpA. As control treatment, the animal derived surfactant Poractant alfa (Curosurf®, 80 mg/ml, Chiesi Farmaceutici SpA, Parma, Italy) was used, which is frequently used in clinical practice. All preparations were supplied by Chiesi Farmaceutici SpA (Parma, Italy). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","10","Matthias Seehase","MS",11,TRUE,5,8,6,5,TRUE,TRUE,FALSE,0,NA,FALSE
